Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude+Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Articles published by Orca Bio
Orca Bio Appoints Bijan Nejadnik, M.D., as Chief Medical Officer
Today 7:38 EDT
From
Orca Bio
Via
Business Wire
Orca Bio Announces U.S. FDA Regenerative Medicine Advanced Therapy (RMAT) Designation Granted to Orca-Q® for the Treatment of High-Risk Hematologic Malignancies
April 28, 2026
From
Orca Bio
Via
Business Wire
Orca Bio Announces FDA Review Extension of BLA for Orca-T for the Treatment of Hematologic Malignancies
April 01, 2026
From
Orca Bio
Via
Business Wire
Orca Bio to Present Clinical Data on Its Pipeline of High-Precision Cell Therapies at the 52nd Annual Meeting of the EBMT
March 02, 2026
From
Orca Bio
Via
Business Wire
Orca Bio Presents New Data at the 2026 Tandem Meetings of ASTCT® and CIBMTR® Reinforcing Orca-T® as a Durable, High-Precision Cell Therapy for Hematological Malignancies
February 05, 2026
From
Orca Bio
Via
Business Wire
Orca Bio to Present New Clinical Data on Its High-Precision Cell Therapies at the 2026 Tandem Meetings of ASTCT® and CIBMTR®
January 21, 2026
From
Orca Bio
Via
Business Wire
Orca Bio Announces $250M in Aggregate Financing in Preparation for Potential Commercialization
January 09, 2026
From
Orca Bio
Via
Business Wire
Orca Bio to Present at the 44th Annual J.P. Morgan Healthcare Conference
January 05, 2026
From
Orca Bio
Via
Business Wire
Orca Bio Announces Orca-T® Phase 3 Data Published in Blood Demonstrate Significant Improvement in Survival Free from Chronic Graft versus Host Disease in Patients with Hematological Malignancies
December 15, 2025
From
Orca Bio
Via
Business Wire
Orca Bio Presents New Clinical Data on Orca-T® in Older Patients Using Reduced Intensity Conditioning Plus New Analyses from the Precision-T Phase 3 Study at the 67th ASH Annual Meeting
December 06, 2025
From
Orca Bio
Via
Business Wire
Orca Bio to Present New Clinical Data on Its High-Precision Cell Therapies at the 67th American Society of Hematology Annual Meeting
November 03, 2025
From
Orca Bio
Via
Business Wire
Orca Bio Announces FDA Acceptance and Priority Review of the Biologics License Application (BLA) for Orca-T® to Treat Hematological Malignancies
October 06, 2025
From
Orca Bio
Via
Business Wire
Orca Bio Appoints Key Executives Including Steve Gavel as Chief Commercial Officer
June 04, 2025
From
Orca Bio
Via
Business Wire
Orca Bio Announces Leadership Updates
May 12, 2025
From
Orca Bio
Via
Business Wire
Orca Bio Announces Positive Results from the Pivotal Phase 3 Study of Investigational Orca-T® Compared to Allogeneic Stem Cell Transplant for the Treatment of Hematologic Malignancies
March 17, 2025
From
Orca Bio
Via
Business Wire
Orca Bio’s Orca-T® Meets Primary Endpoint in the Pivotal Precision-T Phase 3 Clinical Study for Hematologic Malignancies
February 10, 2025
From
Orca Bio
Via
Business Wire
Orca Bio to Present at the 43rd Annual J.P. Morgan Healthcare Conference
January 06, 2025
From
Orca Bio
Via
Business Wire
Orca Bio Presents Three-Year Survival Data with Orca-T® in Patients with Hematological Malignancies at the 66th ASH Annual Meeting
December 08, 2024
From
Orca Bio
Via
Business Wire
Orca Bio Presents Clinical Results on Use of Orca-Q® without GvHD Prophylaxis in Patients with Hematological Malignancies at the 66th ASH Annual Meeting
December 07, 2024
From
Orca Bio
Via
Business Wire
Orca Bio to Present Clinical Data on Its High-Precision Cell Therapies at the 66th American Society of Hematology Annual Meeting
November 05, 2024
From
Orca Bio
Via
Business Wire
Orca Bio Announces Completion of Patient Enrollment for the Precision-T Phase 3 Study of Orca-T
June 05, 2024
From
Orca Bio
Via
Business Wire
Orca Bio to Present Positive Clinical Outcomes with Orca-T in Patients with AML at 2024 ASCO Annual Meeting
May 23, 2024
From
Orca Bio
Via
Business Wire
Orca Bio to Present Positive Clinical Data on Orca-T at the 50th Annual Meeting of the EBMT
April 11, 2024
From
Orca Bio
Via
Business Wire
Orca Bio Presents Promising Data on Orca-T in Two Oral Presentations at the 2024 Tandem Meetings of ASTCT® and CIBMTR®
February 23, 2024
From
Orca Bio
Via
Business Wire
Orca Bio to Present at the 42nd Annual J.P. Morgan Healthcare Conference
January 03, 2024
From
Orca Bio
Via
Business Wire
Orca Bio Presents Positive Data Demonstrating the Potential for Orca-T and Orca-Q to Expand Treatment to Additional Patient Groups at the 65th ASH Annual Meeting
December 09, 2023
From
Orca Bio
Via
Business Wire
Orca Bio to Present Positive Clinical Data on its Novel High-Precision Cell Therapies at the 65th American Society of Hematology Annual Meeting
November 02, 2023
From
Orca Bio
Via
Business Wire
Orca Bio Presents Positive Data Reinforcing Clinical Profile of Orca-T and Orca-Q at 2023 Transplantation & Cellular Therapy Meetings of ASTCT and CIBMTR
February 16, 2023
From
Orca Bio
Via
Business Wire
Orca Bio to Present at the 41st Annual J.P. Morgan Healthcare Conference
January 06, 2023
From
Orca Bio
Via
Business Wire
Orca Bio Presents Encouraging Interim Clinical Data on Orca-Q in Haploidentical Allogeneic Hematopoietic Stem Cell Transplants at 64th ASH Annual Meeting
December 12, 2022
From
Orca Bio
Via
Business Wire
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
